Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

In AML, collapse prevents relapse

Aug. 13, 2020

5'-nucleotidase inhibitors discovered by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical

Aug. 12, 2020

Ascentage Pharma, University of Michigan patent Mcl-1 inhibitors

Aug. 12, 2020

FDA issues complete response letter for Pedmark

Aug. 12, 2020

Camphor Pharmaceuticals synthesizes new prostanoid EP4 receptor antagonists

Aug. 12, 2020

Medshine Discovery discloses new TGFBR1 inhibitors

Aug. 12, 2020

New triple-modal nanoparticle therapy overcomes drug resistance in bladder cancer models

Aug. 11, 2020

Phase III data show ensartinib significantly prolongs PFS over crizotinib in ALK-positive NSCLC

Aug. 11, 2020

New RIP-1 kinase 1 inhibitors synthesized at Beijing Scitech-Mq Pharmaceuticals

Aug. 11, 2020

New protein kinase inhibitors discovered at Voronoi

Aug. 11, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...